search
Back to results

Brain Exercise and Addiction Trial (BEAT)

Primary Purpose

Cannabis Use Disorder, Moderate, Cannabis Use Disorder, Severe

Status
Completed
Phase
Not Applicable
Locations
Australia
Study Type
Interventional
Intervention
High Intensity Interval Training
Strength and Resistance Training
Sponsored by
Monash University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Cannabis Use Disorder, Moderate

Eligibility Criteria

20 Years - 55 Years (Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Aged 20-55 years
  2. Voluntary and able to provide informed consent
  3. Fluent in English
  4. Current moderate - severe cannabis use disorder
  5. Major history of cannabis use (i.e. ≥3 days per week on average for ≥4 of the past 6 years)
  6. Capacity to tolerate physical exercise according to 'Fitness to Exercise'

Exclusion Criteria:

  1. Have a history of cardiovascular disease, high blood pressure, musculoskeletal injury or other condition that would preclude safe engagement in VO2 max fitness testing and/or regular physical exercise
  2. Severe claustrophobia, non-MR compatible metallic implant, or other contraindication to MRI scanning
  3. Lifetime history of significant neurological illness, or moderate - severe brain injury,
  4. Current major unstable medical illness or chronic pain condition
  5. Lifetime history of schizophrenia, schizoaffective disorder, OCD, PTSD, bipolar disorder
  6. Current significant depression or anxiety that precludes ability to reliably engage in the exercise program
  7. Current moderate - severe substance use disorder for substances other than cannabis (excluding nicotine)
  8. Currently pregnant or lactating
  9. Shift work employment schedule within the prior 6-months
  10. Have engaged in ≥5 sessions of HITT or resistance training within the past 12-months
  11. History of treatment with antipsychotic medications
  12. Current participation in psychosocial treatment for substance use disorder
  13. Other psychoactive medications or psychosocial treatments will be considered on a case-by-case basis. Where a current psychoactive medication is deemed acceptable, both dose and type must have been stable for a minimum of four weeks prior to baseline assessment, and remain stable throughout the 12-week exercise phase of the study.

Sites / Locations

  • Monash University, BrainPark

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

High Intensity Physical Training

Low Intensity Physical Training

Arm Description

12-week, 36 session, cardiorespiratory-focussed physical exercise program delivered by an accredited exercise physiologist

12- week, 36 session, strength-focussed physical exercise program delivered by an accredited exercise physiologist

Outcomes

Primary Outcome Measures

Change in hippocampal integrity
Composite score derived from three hippocampal health indices: volume (structural MRI), connectivity (DTI), neuronal health (MRS NAA) calculated as described in Yucel et al (2016), doi:10.1038/tp.2015.201.

Secondary Outcome Measures

Change in cannabis use
Time line follow back
Change in cannabis dependence
Severity of Dependence Scale (SDS; range = 0-15 higher scores indicate higher dependence
Change in cannabis craving
Penn Craving Scale (PCS; range = 0 - 30 higher scores indicate greater craving)
Change in depression symptoms
Quick Inventory of Depressive Symptomology (QUIDS; range = 0 - 27 higher scores indicate greater depression symptom severity)
Change in anxiety symptoms
StateTrait Anxiety Inventory (STAI; range = 20 to 80, higher scores indicate greater anxiety)
Change in resilience
Connor David Resilience Scale (CDRS; range = 0-100 higher scores indicate higher resilience)
Change in coping skills
Perceived Stress Scale (10 item; range = 0 - 40 higher scores indicate greater stress)
Change in sleep quality
Pittsburgh Sleep Quality Index (PSQI; range = 0 to 21 higher scores indicate worse sleep quality)
Change in mental wellbeing
Warwick Edinburgh Mental Wellbeing Scale (WEMWBS; range = 14-70 higher scores indicate increased mental well being)
Change in quality of life
Quality of Life and Satisfaction Questionnaire - Short Form (QOL-SF; range = 70 higher scores indicate greater life satisfaction and enjoyment)
Change in memory
Rey Auditory Verbal Learning Test (RAVLT)
Change in associative memory
Paired Associates Learning Task (PAL)
Change in visual memory
Figural Memory Tasks
Change in cardiorespiratory fitness
VO2 max

Full Information

First Posted
May 13, 2021
Last Updated
October 18, 2023
Sponsor
Monash University
Collaborators
Turning Point
search

1. Study Identification

Unique Protocol Identification Number
NCT04902092
Brief Title
Brain Exercise and Addiction Trial
Acronym
BEAT
Official Title
Brain Exercise and Addiction Trial: Efficacy of a 12-week Aerobic Exercise Regime for Restoring 'Brain Health' in Cannabis Users
Study Type
Interventional

2. Study Status

Record Verification Date
October 2023
Overall Recruitment Status
Completed
Study Start Date
January 23, 2019 (Actual)
Primary Completion Date
June 10, 2022 (Actual)
Study Completion Date
November 21, 2022 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Monash University
Collaborators
Turning Point

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Heavy cannabis use is associated with substantive learning and memory impairments and elevated risk of psychopathology. It has been repeatedly demonstrated that the hippocampus, centrally implicated in these processes, is particularly vulnerable to the deleterious effects of prolonged exposure to cannabis. This deterioration of hippocampal structure, function, and biochemistry can be reversed, but this requires two or more years of abstinence from cannabis. However, most heavy cannabis users find it extremely difficult to maintain abstinence over extended periods and current treatments for cannabis use disorders are inadequate. There is a pressing clinical need for an intervention that rapidly accelerates hippocampal recovery, ameliorates the associated cognitive impairments and mental health symptoms, and leads to improved treatment outcomes. One promising candidate is physical exercise. In addition to the well-known physical health benefits, regular exercise also has a potent positive effect on brain health. The current study will investitive the capacity of two different neuroscientifically-informed 12-week exercise programs can restore brain health for heavy long term cannabis users.
Detailed Description
Heavy cannabis use is associated with substantive learning and memory impairments and elevated risk of psychopathology. It has been repeatedly demonstrated that the hippocampus, centrally implicated in these processes, is particularly vulnerable to the deleterious effects of prolonged exposure to cannabis. This deterioration of hippocampal structure, function, and biochemistry can be reversed, but this requires two or more years of abstinence from cannabis. However, most heavy cannabis users find it extremely difficult to maintain abstinence over extended periods and current treatments for cannabis use disorders are inadequate. There is a pressing clinical need for an intervention that rapidly accelerates hippocampal recovery, ameliorates the associated cognitive impairments and mental health symptoms, and leads to improved treatment outcomes. One promising candidate is physical exercise. In addition to the well-known physical health benefits, regular exercise also has a potent positive effect on brain health and can increase the size of the hippocampus. It's not yet known how much or what kind of exercise produces the best results. This study has been designed to compare the effects of two different exercise programs. 12 weeks of regular HIIT exercise 12 weeks of regular strength training The research team are investigating whether the programs have a positive impact on brain health and, if they do, whether one is more effective than the other. The research team will also measure whether engaging in either program leads to a reduction in cannabis consumption, and improvements in thinking skills, mental health, and general wellbeing.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cannabis Use Disorder, Moderate, Cannabis Use Disorder, Severe

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
65 (Actual)

8. Arms, Groups, and Interventions

Arm Title
High Intensity Physical Training
Arm Type
Active Comparator
Arm Description
12-week, 36 session, cardiorespiratory-focussed physical exercise program delivered by an accredited exercise physiologist
Arm Title
Low Intensity Physical Training
Arm Type
Active Comparator
Arm Description
12- week, 36 session, strength-focussed physical exercise program delivered by an accredited exercise physiologist
Intervention Type
Behavioral
Intervention Name(s)
High Intensity Interval Training
Intervention Description
Exercise sessions will commence with an initial 3-week accustomization period whereby training load will increase incrementally from 2 x 45min sessions with effort peaking at 60% VO2 max (week 1) increasing to 3 x 45minute with effort peaking at 80% VO2max (week 3). Participants will transition to the full HIIT protocol for the remaining weeks. The HIIT component will comprise a work-rest ratio of ≥1:1minutes, with alternating exertion epochs at >80% VO2max and <60% VO2max. As VO2max is likely to increase as fitness improves toward the end of the 3-month program, adjustments to HIIT will be made by the exercise physiologist based on real-time heart rate monitoring, ensuring greater accuracy in participants achieving their heart rate targets.
Intervention Type
Behavioral
Intervention Name(s)
Strength and Resistance Training
Intervention Description
Exercise sessions will comprise a combination of strength, coordination and mobility exercises. The strength component will consist of 2-3 sets of resistance exercises at ≤70% of a predicted 1 repetition maximum, targeting all body segments. Heart rate tracking will occur to ensure participants do not exceed 70% v02 (or exceed Lactate Threshold).
Primary Outcome Measure Information:
Title
Change in hippocampal integrity
Description
Composite score derived from three hippocampal health indices: volume (structural MRI), connectivity (DTI), neuronal health (MRS NAA) calculated as described in Yucel et al (2016), doi:10.1038/tp.2015.201.
Time Frame
Baseline (0 months), post (3 months)
Secondary Outcome Measure Information:
Title
Change in cannabis use
Description
Time line follow back
Time Frame
Baseline (0 months), post (3 months), follow up (6 months)
Title
Change in cannabis dependence
Description
Severity of Dependence Scale (SDS; range = 0-15 higher scores indicate higher dependence
Time Frame
Baseline (0 months), post (3 months), follow up (6 months)
Title
Change in cannabis craving
Description
Penn Craving Scale (PCS; range = 0 - 30 higher scores indicate greater craving)
Time Frame
Baseline (0 months), post (3 months), follow up (6 months)
Title
Change in depression symptoms
Description
Quick Inventory of Depressive Symptomology (QUIDS; range = 0 - 27 higher scores indicate greater depression symptom severity)
Time Frame
Baseline (0 months), post (3 months), follow up (6 months)
Title
Change in anxiety symptoms
Description
StateTrait Anxiety Inventory (STAI; range = 20 to 80, higher scores indicate greater anxiety)
Time Frame
Baseline (0 months), post (3 months), follow up (6 months)
Title
Change in resilience
Description
Connor David Resilience Scale (CDRS; range = 0-100 higher scores indicate higher resilience)
Time Frame
Baseline (0 months), post (3 months), follow up (6 months)
Title
Change in coping skills
Description
Perceived Stress Scale (10 item; range = 0 - 40 higher scores indicate greater stress)
Time Frame
Baseline (0 months), post (3 months), follow up (6 months)
Title
Change in sleep quality
Description
Pittsburgh Sleep Quality Index (PSQI; range = 0 to 21 higher scores indicate worse sleep quality)
Time Frame
Baseline (0 months), post (3 months), follow up (6 months)
Title
Change in mental wellbeing
Description
Warwick Edinburgh Mental Wellbeing Scale (WEMWBS; range = 14-70 higher scores indicate increased mental well being)
Time Frame
Baseline (0 months), post (3 months), follow up (6 months)
Title
Change in quality of life
Description
Quality of Life and Satisfaction Questionnaire - Short Form (QOL-SF; range = 70 higher scores indicate greater life satisfaction and enjoyment)
Time Frame
Baseline (0 months), post (3 months), follow up (6 months)
Title
Change in memory
Description
Rey Auditory Verbal Learning Test (RAVLT)
Time Frame
Baseline (0 months), post (3 months), follow up (6 months)
Title
Change in associative memory
Description
Paired Associates Learning Task (PAL)
Time Frame
Baseline (0 months), post (3 months), follow up (6 months)
Title
Change in visual memory
Description
Figural Memory Tasks
Time Frame
Baseline (0 months), post (3 months)
Title
Change in cardiorespiratory fitness
Description
VO2 max
Time Frame
Baseline (0 months), post (3 months)

10. Eligibility

Sex
All
Minimum Age & Unit of Time
20 Years
Maximum Age & Unit of Time
55 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Aged 20-55 years Voluntary and able to provide informed consent Fluent in English Current moderate - severe cannabis use disorder Major history of cannabis use (i.e. ≥3 days per week on average for ≥4 of the past 6 years) Capacity to tolerate physical exercise according to 'Fitness to Exercise' Exclusion Criteria: Have a history of cardiovascular disease, high blood pressure, musculoskeletal injury or other condition that would preclude safe engagement in VO2 max fitness testing and/or regular physical exercise Severe claustrophobia, non-MR compatible metallic implant, or other contraindication to MRI scanning Lifetime history of significant neurological illness, or moderate - severe brain injury, Current major unstable medical illness or chronic pain condition Lifetime history of schizophrenia, schizoaffective disorder, OCD, PTSD, bipolar disorder Current significant depression or anxiety that precludes ability to reliably engage in the exercise program Current moderate - severe substance use disorder for substances other than cannabis (excluding nicotine) Currently pregnant or lactating Shift work employment schedule within the prior 6-months Have engaged in ≥5 sessions of HITT or resistance training within the past 12-months History of treatment with antipsychotic medications Current participation in psychosocial treatment for substance use disorder Other psychoactive medications or psychosocial treatments will be considered on a case-by-case basis. Where a current psychoactive medication is deemed acceptable, both dose and type must have been stable for a minimum of four weeks prior to baseline assessment, and remain stable throughout the 12-week exercise phase of the study.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Murat Yucel
Organizational Affiliation
Monash University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Monash University, BrainPark
City
Melbourne
State/Province
Victoria
ZIP/Postal Code
3800
Country
Australia

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Brain Exercise and Addiction Trial

We'll reach out to this number within 24 hrs